Emend
NDC Package 54868-5231-2
Package Information
Emend is aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Marketed by Physicians Total Care, Inc., this product is identified by NDC 54868-5231 and is authorized under FDA application NDA021549.
Identification & Billing
- RxCUI: 403810 - aprepitant 80 MG Oral Capsule
- RxCUI: 403811 - aprepitant 125 MG Oral Capsule
- RxCUI: 404465 - Emend 80 MG Oral Capsule
- RxCUI: 404465 - aprepitant 80 MG Oral Capsule [Emend]
- RxCUI: 404466 - Emend 125 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54868 - Physicians Total Care, Inc.
- 54868-5231 - Emend
- 54868-5231-2 - 2 CAPSULE in 1 DOSE PACK
- 54868-5231 - Emend
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54868-5231). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54868-5231-2 identifies a specific commercial package of 2 capsule in 1 dose pack of Emend, labeled by Physicians Total Care, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Physicians Total Care, Inc. on June 29, 2005. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Aprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting.
How is this Physicians Total Care, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54868523102. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.